Karen Uzark1, Victor Zak2, Peter Shrader2, Brian W McCrindle3, Elizabeth Radojewski3, James W Varni4, Kaitlyn Daniels5, Jill Handisides6, Kevin D Hill7, Linda M Lambert8, Renee Margossian6, Victoria L Pemberton9, Wyman W Lai10, Andrew M Atz11. 1. University of Michigan Mott Children's Hospital, Ann Arbor, MI. Electronic address: karenu@med.umich.edu. 2. New England Research Institutes, Watertown, MA. 3. University of Toronto Hospital for Sick Children, Toronto, Ontario, Canada. 4. Texas A & M University, College Station, TX. 5. Children's Hospital of Philadelphia, Philadelphia, PA. 6. Boston Children's Hospital, Boston, MA. 7. Duke University Medical Center, Durham, NC. 8. Primary Children's Hospital, Salt Lake City, UT. 9. National Heart, Lung, and Blood Institute, Bethesda, MD. 10. Columbia University Medical Center, New York, NY. 11. Medical University of South Carolina, Charleston, SC.
Abstract
OBJECTIVES: To assess self-reported quality of life (QOL) in a large multicenter cohort of adolescent and young adults surviving Fontan. STUDY DESIGN: Cross-sectional. The Pediatric Quality of Life Inventory (PedsQL) was administered to 408 survivors of Fontan ages 13-25 years enrolled in the Pediatric Heart Network Fontan Follow-up Study. Subjects also completed either the Child Health Questionnaire (age <19 years) or Short Form Health Survey (age ≥ 19 years). PedsQL data were compared with matched controls without a chronic health condition. Correlations between the measures were examined. RESULTS: Mean PedsQL scores for subjects receiving Fontan were significantly lower than those for the control group for physical and psychosocial QOL (P < .001). Overall, 45% of subjects receiving Fontan had scores in the clinically significant impaired range for physical QOL with 30% in the impaired range for psychosocial QOL. For each 1 year increase in age, the physical functioning score decreased by an average of 0.76 points (P = .004) and the emotional functioning score decreased by an average of 0.64 points (P = .03). Among subjects ≥19 years of age, the physical functioning score decreased by an average of 2 points for each year increase in age (P = .02). PedsQL scale scores were significantly correlated with conceptually related Child Health Questionnaire (P < .001) and Short Form Health Survey scores (P < .001). CONCLUSIONS: Survivors of Fontan are at risk for significantly impaired QOL which may decline with advancing age. Routine assessment of QOL is essential to inform interventions to improve health outcomes. The PedsQL allowed QOL assessment from pediatrics to young adulthood. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00132782.
OBJECTIVES: To assess self-reported quality of life (QOL) in a large multicenter cohort of adolescent and young adults surviving Fontan. STUDY DESIGN: Cross-sectional. The Pediatric Quality of Life Inventory (PedsQL) was administered to 408 survivors of Fontan ages 13-25 years enrolled in the Pediatric Heart Network Fontan Follow-up Study. Subjects also completed either the Child Health Questionnaire (age <19 years) or Short Form Health Survey (age ≥ 19 years). PedsQL data were compared with matched controls without a chronic health condition. Correlations between the measures were examined. RESULTS: Mean PedsQL scores for subjects receiving Fontan were significantly lower than those for the control group for physical and psychosocial QOL (P < .001). Overall, 45% of subjects receiving Fontan had scores in the clinically significant impaired range for physical QOL with 30% in the impaired range for psychosocial QOL. For each 1 year increase in age, the physical functioning score decreased by an average of 0.76 points (P = .004) and the emotional functioning score decreased by an average of 0.64 points (P = .03). Among subjects ≥19 years of age, the physical functioning score decreased by an average of 2 points for each year increase in age (P = .02). PedsQL scale scores were significantly correlated with conceptually related Child Health Questionnaire (P < .001) and Short Form Health Survey scores (P < .001). CONCLUSIONS: Survivors of Fontan are at risk for significantly impaired QOL which may decline with advancing age. Routine assessment of QOL is essential to inform interventions to improve health outcomes. The PedsQL allowed QOL assessment from pediatrics to young adulthood. TRIAL REGISTRATION: ClinicalTrials.gov: NCT00132782.
Authors: Ana M Silva; Cláudia Vaz; Maria E G Areias; Daniela Vieira; Cidália Proença; Victor Viana; Cláudia Moura; José C Areias Journal: Cardiol Young Date: 2011-06-08 Impact factor: 1.093
Authors: Nancy A Pike; Lorraine S Evangelista; Lynn V Doering; Deborah Koniak-Griffin; Alan B Lewis; John S Child Journal: Congenit Heart Dis Date: 2011 Jan-Feb Impact factor: 2.007
Authors: Flávio Miguel Teixeira; Rosália Maria Coelho; Cidália Proença; Ana Margarida Silva; Daniela Vieira; Cláudia Vaz; Cláudia Moura; Victor Viana; José Carlos Areias; Maria Emília Guimarães Areias Journal: Pediatr Cardiol Date: 2011-06-28 Impact factor: 1.655
Authors: Andrew M Atz; Victor Zak; Roger E Breitbart; Steven D Colan; Sara K Pasquali; Daphne T Hsu; Minmin Lu; Lynn Mahony; Stephen M Paridon; Michael D Puchalski; Tal Geva; Brian W McCrindle Journal: Congenit Heart Dis Date: 2011-03-25 Impact factor: 2.007
Authors: Linda M Lambert; L LuAnn Minich; Jane W Newburger; Minmin Lu; Victoria L Pemberton; Ellen A McGrath; Andrew M Atz; Mingfen Xu; Elizabeth Radojewski; Darlene Servedio; Brian W McCrindle Journal: Pediatrics Date: 2009-10-19 Impact factor: 7.124
Authors: Cedric Manlhiot; Stevan Knezevich; Elizabeth Radojewski; Geraldine Cullen-Dean; William G Williams; Brian W McCrindle Journal: Can J Cardiol Date: 2009-09 Impact factor: 5.223
Authors: Linda M Lambert; Brian W McCrindle; Victoria L Pemberton; Danielle Hollenbeck-Pringle; Andrew M Atz; Chitra Ravishankar; M Jay Campbell; Carolyn Dunbar-Masterson; Karen Uzark; Martha Rolland; Felicia L Trachtenberg; Shaji C Menon Journal: Am Heart J Date: 2020-04-04 Impact factor: 4.749
Authors: Gali S Kolt; Barbara R Ferdman; Jessica Y Choi; Janine Henson; Van-Trang Nguyen; Emily A Farkas; Vinicius Jds Nina; Rachel Vah Nina; Renzo O CiFuentes; William F Zeman; John E Connett; Aubyn Marath Journal: Cardiol Young Date: 2020-02 Impact factor: 1.093
Authors: Laura Mercer-Rosa; Mark A Fogel; Zhenglun Alan Wei; Phillip M Trusty; Michael Tree; Elaine Tang; Maria Restrepo; Kevin K Whitehead; Amy Cassedy; Stephen M Paridon; Ajit Yoganathan; Bradley S Marino Journal: Ann Thorac Surg Date: 2022-02-01 Impact factor: 5.102
Authors: Christina E Holbein; Nicholas D Fogleman; Kevin Hommel; Silke Apers; Jessica Rassart; Philip Moons; Koen Luyckx; Maayke A Sluman; Junko Enomoto; Bengt Johansson; Hsiao-Ling Yang; Mikael Dellborg; Raghavan Subramanyan; Jamie L Jackson; Werner Budts; Adrienne H Kovacs; Stacey Morrison; Martha Tomlin; Kathy Gosney; Alexandra Soufi; Katrine Eriksen; Corina Thomet; Malin Berghammer; Luis Alday; Edward Callus; Susan M Fernandes; Maryanne Caruana; Samuel Menahem; Stephen C Cook; Gwen R Rempel; Kamila White; Paul Khairy; Shelby Kutty; Gruschen Veldtman Journal: Congenit Heart Dis Date: 2018-01-03 Impact factor: 2.007
Authors: Andrew M Atz; Victor Zak; Lynn Mahony; Karen Uzark; Nicholas D'agincourt; David J Goldberg; Richard V Williams; Roger E Breitbart; Steven D Colan; Kristin M Burns; Renee Margossian; Heather T Henderson; Rosalind Korsin; Bradley S Marino; Kaitlyn Daniels; Brian W McCrindle Journal: J Am Coll Cardiol Date: 2017-06-06 Impact factor: 24.094
Authors: Nigel E Drury; Victoria M Stoll; Chris J Bond; Akshay J Patel; Suzie Hutchinson; Paul F Clift Journal: Cardiol Young Date: 2018-12-21 Impact factor: 1.093
Authors: Bryan H Goldstein; Elaine M Urbina; Philip R Khoury; Zhiqian Gao; Michelle A Amos; Wayne A Mays; Andrew N Redington; Bradley S Marino Journal: J Am Heart Assoc Date: 2016-09-24 Impact factor: 5.501